What we do

CPhI Worldwide 2018 Madrid, Spain

   On October 9 – 11, Biovico will be an exhibitor at the international CPhI Worldwide 2018 in Madrid. They are the world’s largest trade fairs for the pharmaceutical industry, equipment manufacturers and providers of pharmaceutical services.

CPhI Worldwide 2018 is an excellent opportunity to establish new business contacts and face-to-face meetings with existing partners and clients.

We invite you to visit our stand No. 9J72.

banner (1)

Biolevox Chondro changes its name to Chondrovox

We kindly inform, that due to the development of export and expansion into foreign markets, the product Biolevox Chondro from our company portfolio has officially changed its name to Chondrovox.

The change results from the international factors which forced the removal of the “Bio” prefix from the previous name of the product. However, during the transition period, products under both names may be traded.

Vitafoods Europe 2017

The annual event Vitafoods Europe will take place in Geneva on May 9-11. It is the biggest fair in Europe dedicated to dietary supplements and functional food.

This event has become a permanent part of calendar gathering the most important dates for Biovico. During this year’s edition, the newest product of the company will be presented – Biolevox One, intraarticular hyaluronic acid having one of the highest concentrations of hyaluronic acid in one dose on the European market. The second product promoted during the event will be Levidor, which contains a patented formula consisting of extracts from Nigella sativa seeds and Angelica archangelica.

Vitafoods fair is an excellent opportunity for networking. The event brings together science and industry professionals and offers space to share knowledge and make a valuable collaboration.

We invite you to visit our stand J44 on 9th of May this year in Geneva.


Biovico becomes a leader of intraarticular hyaluronic acids

Biovico company received a grant for the development of hyaluronic acid with added value under the program “szybka ścieżka” NCBR.

The aim of the project is to develop a new generation proprietary product, and the entirety of works will be carried out on the premises of our own laboratory located in the Pomeranian Science and Technology Park in Gdynia. Modern laboratory together with the specialized scientific staff enable self-realization of the entire process of creating a new product.

Today Biovico is the undisputed leader in intraarticular hyaluronic acids in Poland. Moreover, the development of a new product opens even wider opportunities for the company in foreign markets.

The main product from the company portfolio – Biolevox HA – supplies over 50% of the Polish market and is successfully distributed to foreign markets. Last year alone, the product developed better than the whole market of intraarticular hyaluronic acids in Poland. The sales dynamics show that our Biolevox Ha increased by 55%, while the entire market increased by 21%.

When we started distributing our product in 2012 the market share was only 0.2%. The past 4 years have shown that unmatched quality of the preparation convinced both physicians and patients, gaining recognition of over 50% of the current intraarticular hyaluronic acid market in Poland.

The funding received for the development of hyaluronic acid and the development of a new generation product is important for Biovico, as its primary goal and mission translate into providing patients with the highest quality medical devices and innovative solutions for every stage of orthopedic and rheumatic diseases.

Biovico has received a grant for the best research and development project

Biovico company has received a grant for the best research and development project!

The aim of the project is to develop and implement innovative biomaterials for complex regeneration of cartilage tissue, which is supposed to result in the easier process of patient rehabilitation, minimizing potential problems and creating ideal conditions for biological, natural self-healing. The grant, that we received, is the next step to reach this aim!

Find more details here: http://ppnt.pl/pl/aktualnosci/ppnt/firma-z-gdyni-z-dofinansowaniem-za-najlepszy-projekt-badawczo-rozwojowy

XLI Polish Society of Orthopaedics and Traumatology Congress

On September 22-24 in Lublin took place XLI Polish Society of Orthopaedics and Traumatology Congress.

The main topics that were discussed during this year’s Congress are: musculoskeletal oncology, pelvic and lower limb injuries – important not only for the orthopedic environment but above all still relevant and important for the development of society.

During the Congress, M.D. Przemysław Łangowski and M.D., Dr hab. Przemysław Paradowski – prominent specialists from Centrum Medyczne Bimed shared their knowledge and experience. The subject of a presentation was „Fracture of the talus bone and Chopart’s joint damage.”

In addition, the Convention was attended by specialists and scientists from different regions of the world. This very important exchange of knowledge and experience could not be missed by Biovico, who underlines the significance of development in the field of orthopaedics and traumatology. lay on the field of orthopedics and traumatology.

Worlds Biomaterials Congress 2016

10th World Biomaterials Congress was held in Montreal on the 17-22.05.2016. The largest get-together of biomaterials experts is an incredible opportunity to exchange the information of current trends and new products on the market. Therefore Biovico couldn’t miss such an opportunity.

This year edition was the largest, it has delivered more than 1,200 presentations, an extensive conference program consisted lectures, symposia and workshops. This event, every four years, gathers in one place business professionals from around the world, including representatives of business, doctors, legal experts, consultants and students.

Biovico Laboratories: where nature meets science

Biotechnology is one of the biggest growth areas in research, and with technological advancements and stricter regulation of drugs, medical products, diet supplements and foods we are striving to ensure even better quality control. We are always working to enhance our products to make them meet all customer expectations.

Biovico’s stunning growth rate lead us to relocate our newest research and development laboratory to the prestigious Pomeranian Science and Technology Park in Gdynia, Poland. Since 2013, we have been developing our products in laboratories that offer the world’s best and most advanced equipment. Combining years of experience with cutting-edge technology, we create an ever-growing range of studies and services. At over 200 square meters, three Biovico research units (extraction and analysis, biopolymers and biological research units) can be found.

Extraction and analysis is a unit focused on technological processes, active compounds and industrial biotechnology. In the polymers unit, our employees create formulas and develop innovative viscosupplements and regenerative drugs and modify the structures of nanocellulose wound dressings. The biological research unit deals with the bio functions of developed prototypes, biological activity evaluation of products and stem-cell therapies in core therapeutic areas.

Our laboratory team are highly experienced researchers eager to utilize the latest developments in medicine. Led by Krzysztof Lemke, PhD, our dedicated personnel consists of pharmacy, medicine, chemistry and biotechnology specialists. Professional, innovative and experienced, we are always looking for opportunities for personal growth. The synergy of knowledge, specialist expertise and cutting-edge equipment has pushed us to the rising top-tier of pharmaceutical companies in the country.

Always searching for better solutions, we are working to expand our offer and research. Recently, we added ThymoXanTM and INFLOX® to our products; the first is available on the market, while the latter is now being tested clinically.

A range of Biovico products are still in development. We are continuing our research on advanced wound care products such as liquid and enriched dressings, specialist veterinary products and nutraceuticals. With these additions, we are aspiring to meet and surpass the expectations of our customers. Biovico ensures professional expert evaluation of our product parameters and characteristics. Consumer care and an environmental mindset is our priority and mission.

Vitafoods Europe 2016

Vitafoods Europe Event will take place in Geneva from 10th to 12th of May. Like in previous years, Biovico representation will be there.

Vitafoods Europe – the global nutraceutical event is an international meeting of the highest quality. Its goal is to promote health and present the development of food additives trade. The exhibitions gather key companies of nutraceuticals, dietary supplements, food and functional drinks industries. The exhibitions are accompanied by a scientific conference, forums, and lectures sponsored by the exhibitors. All of these elements let you expand your knowledge in the field of innovative solutions for human health. This event brings together experts from science and industry facilitating the exchange of knowledge and the establishment of beneficial cooperation.

Vitafoods Europe Event concentrates on the dynamic development process of new health solutions. Biovico company identifies with mission and character of this event. We know that only safe, effective, and available innovations are the key to success. Biovico has been the active exhibitor since the beginning of exhibitions.

Find more information about Vitafoods Europe on the official website: http://www.vitafoods.eu.com/

Innovative surgical solutions in the field of orthopaedics

Orthopaedic treatment raises many questions and doubts among patients and doctors. Therefore, our next goal is to develop orthopaedics professionally. Close cooperation with the Swiss company Mathys European Orthopaedics allowed us to introduce innovative surgical solutions in the field of orthopaedics into Biovico’s offer.

The human musculoskeletal system needs precise and high-quality actions in the field of orthopaedics. Each implementation of the artificial joint requires an individual approach that is adjusted to the human anatomy. Proper diagnosis and treatment of defects, deformations and dysfunctions of the musculoskeletal system allows patients to enjoy continuous comfortableness. Together with Mathys European Orthopaedics, we would like to focus on modernising orthopaedics in Poland, increasing the standard and the quality of the research.

Mathys European Orthopaedics has been operating since 1946. It is the leader in the production of endoprostheses, the bone graft substitutes and products used for the cruciate ligaments reconstructions. It seeks to ensure that the products become the quality standard all over the world. Mathys European Orthopaedics is one of the few companies which has such a long tradition as well as significant experience in the field of orthopaedics. In 1963, the specialists from Mathys European Orthopaedics in cooperation with professor Maurice E. Muller have conducted the first successful construction of hip stem. It led to the world’s first implantation of a hip prosthesis in 1972. Subsequently, in 2012, Mathys European Orthopaedics has extended its works on orthopaedics, especially regarding the needs of athletes.

The development of the orthopaedics in close cooperation with doctors and patients is essential for us. The only way to ease the pain and restore the continuous comfortableness is by specially developed preparations of procedure packs. Our priority is the easy rehabilitation process, minimization of the potential issues and creating ideal conditions for biological, which means natural, self-healing.